Send feedback

CHMP2B p.Pro182Leu

c.545C>T · rs369257752 · VCV1376594

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9367 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00136%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
frontotemporal dementia and/or amyotrophic lateral sclerosis 7

Computational evidence

Protein change
AlphaMissense0.9367likely pathogenic
REVEL0.741pathogenic-leaning
SaProtLLR -14.36damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6GERP 2.7, phastCons 1
Regional constrainto/e 1.03unconstrained · MANE · 26 kb · p 0.58 · regional, not allelic
Overall
CADD29.1PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00136% European (non-Finnish) · 16/1,178,742 alleles
Filtering AF 0.000804% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00065%
Overall 0.00112% 18/1,612,228 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,392
European (non-Finnish)grpmax 0.00136% 73,671
African / African-American 0.00134% 74,810

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CHMP2B
Protein
p.Pro182Leu
Coding
c.545C>T
MANE Select
NM_014043
dbSNP
rs369257752
Type
single nucleotide variant
Location
chr3:87253725 (GRCh38)
Gene constraint
LOEUF 1.503 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.26 · 1 PDB
Residue 182
the 'disordered' region
Full CHMP2B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

frontotemporal dementia and/or amyotrophic lateral sclerosis 7 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Behavioral variant of frontotemporal dementia (Orphanet):

Inheritance
Autosomal dominant
Onset
Adult
Prevalence
1-9 / 100 000 (Netherlands)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chmp2b-p-pro182leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown